Phase
Condition
Hearing Impairment
Hearing Loss
Deafness
Treatment
Pure Tone Audiometry Assessment
Quality of Life Questionnaires
Clinical Study ID
Ages < 16 All Genders
Study Summary
Eligibility Criteria
Inclusion
Main Inclusion Criteria:
Participants meeting all the following main inclusion criteria will be eligible to participate in the study:
Aged ≤ 16 years on the date of signed informed consent for cohort 1 and ≤ 10 yearsfor cohort 2;
With a diagnosis of non-syndromic, bilateral, mild to profound, sensorineuralhearing loss (according to the American Speech Language-Hearing Association);
With documented genotyping results showing mutation(s) in GJB2 or OTOF genes;
Written informed consent as required by local regulations.
Either without Cochlear Implant, or with unilateral or bilateral Cochlear Implant(s)
Exclusion
Exclusion Criteria:
Participants presenting with any of the following main exclusion criteria will not be included in the study
Other type of deafness, such as unilateral deafness, persistent conductive deafness,malformation syndrome, syndromic deafness, known familial deafness linked tomutations in other genes than OTOF or GJB2;
Documented genotyping results showing pathogenic mutation(s) in other gene(s) thanGJB2 or OTOF genes in the tested panel;
Unable and/or unwilling to comply with all the protocol requirements and/or studyprocedures.
Study Design
Study Description
Connect with a study center
Necker Hospital
Paris,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.